Get Connected:

 

Latest News

Ellipta Shows Superior Rates of Correct Patient Use Compared with Device Combos
A new study has found that patients with chronic obstructive pulmonary disease (COPD) better manage proper inhaler use with 1 branded single-use device than others.
Top news of the week from The American Journal of Pharmacy Benefits.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
 
A first-of-its-kind study found that mortality in the first year after critical illness is higher among older adults with Medicaid insurance compared to those with Medicare and additional commercial insurance, especially among those discharged to skilled-care facilities.
Antibiotics may worsen the care of some adult patients hospitalized with asthma exacerbations.
Top news of the day from across the health care landscape.
 
Sanofi announced that the FDA has accepted the New Drug Application (NDA) for Zynquista (sotagliflozin).
View More >

From the Journals

New proposed rules for the Medicare Part D drug program could affect the manner in which pharmacy benefit managers administer the program and could impact profitability.
Healthcare stakeholders must evaluate how to use resources more efficiently as it has become clear that driving down prices in one segment of care has not improved medical outcomes for the majority of patients.
This cost analysis demonstrated that onabotulinumtoxinA is one of the least-costly treatment options for inadequately managed overactive bladder syndrome.
An estimation and comparison of the cost of home phototherapy versus biologics over a 3-year time horizon in patients with moderate-to-severe plaque psoriasis.
The study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
Buprenorphine treatment with and without induction was found to decrease costs and utilization in opioid-dependent benefciaries.
Focusing on cost alone could diminish the vital service aspects behind successfully caring for a patient in a specialty pharmacy.
Upcoming Partner Events